Noninvasive fetal blood group antigen genotyping.

IF 2.3 3区 医学 Q2 HEMATOLOGY Blood Transfusion Pub Date : 2025-03-01 Epub Date: 2024-01-29 DOI:10.2450/BloodTransfus.712
Frederik B Clausen, C Ellen van der Schoot
{"title":"Noninvasive fetal blood group antigen genotyping.","authors":"Frederik B Clausen, C Ellen van der Schoot","doi":"10.2450/BloodTransfus.712","DOIUrl":null,"url":null,"abstract":"<p><p>Noninvasive fetal blood group antigen genotyping serves as a diagnostic tool to predict the risk of hemolytic disease of the fetus and newborn in pregnancies of immunized women. In addition, fetal RHD genotyping is used as an antenatal screening to guide targeted use of immunoglobulin prophylaxis in non-immunized RhD negative, pregnant women. Based on testing of cell-free DNA extracted from maternal plasma, these noninvasive assays demonstrate high performance accuracies. Consequently, noninvasive fetal blood group antigen genotyping has become standard care in transfusion medicine.</p>","PeriodicalId":49260,"journal":{"name":"Blood Transfusion","volume":" ","pages":"101-108"},"PeriodicalIF":2.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925261/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2450/BloodTransfus.712","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Noninvasive fetal blood group antigen genotyping serves as a diagnostic tool to predict the risk of hemolytic disease of the fetus and newborn in pregnancies of immunized women. In addition, fetal RHD genotyping is used as an antenatal screening to guide targeted use of immunoglobulin prophylaxis in non-immunized RhD negative, pregnant women. Based on testing of cell-free DNA extracted from maternal plasma, these noninvasive assays demonstrate high performance accuracies. Consequently, noninvasive fetal blood group antigen genotyping has become standard care in transfusion medicine.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无创胎儿血型抗原基因分型。
无创胎儿血型抗原基因分型可作为一种诊断工具,用于预测已接受免疫的孕妇的胎儿和新生儿患溶血性疾病的风险。此外,胎儿 RHD 基因分型还可用作产前筛查,以指导未接受免疫的 RhD 阴性孕妇有针对性地使用免疫球蛋白进行预防。这些无创检测基于对从母体血浆中提取的无细胞 DNA 的检测,具有很高的准确性。因此,无创胎儿血型抗原基因分型已成为输血医学的标准疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Blood Transfusion
Blood Transfusion HEMATOLOGY-
CiteScore
6.10
自引率
2.70%
发文量
91
审稿时长
2 months
期刊介绍: Blood Transfusion welcomes international submissions of Original Articles, Review Articles, Case Reports and Letters on all the fields related to Transfusion Medicine.
期刊最新文献
Effectiveness of oral platelet lysate gel to treat oral mucosal manifestations associated with chronic graft versus host disease. The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia. Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual. Patient Blood Management in pediatric and adolescent bone marrow donors: results from an Italian survey. First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1